Skip to main content

Currently Skimming:

Appendix 6: Epstein-Barr Virus
Pages 177-180

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 177...
... Disease Scenarios For the purposes of the calculation in this report, the committee estimated that 95% of infections manifest as uncomplicated mononucleosis (fever, lymphadenopathy, and pharyngitis)
From page 179...
... Table 4-1 summarizes vaccine development assumptions for all vaccines considered in this report. VACCINE PROGRAM CONSIDERATIONS Target Population The committee's model assumes that immunization with this vaccine will occur during puberty.
From page 180...
... Although the number of people experiencing uncomplicated mononucleosis is far greater than those experiencing complications, slightly more than half of the QALYs lost are attributable to complicated mononucleosis due to the much lower HUI value and the longer duration. If a vaccine program for EBV were implemented today and the vaccine was 100% efficacious and utilized by 100% of the target population, the annualized present value of the health care costs saved would be $12.6 million.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.